Abstract
Observational and some experimental data suggest that hepatitis C virus can manifest in a variety of disease processes outside the liver. The links between hepatitis C virus and membranoproliferative glomerulonephropathy, porphyria cutanea tarda, lichen planus, cryoglobulinemia, diabetes mellitus, B-cell non-Hodgkin’s lymphoma, and thyroiditis are critically reviewed. Based on the available evidence, recommendations for the clinical approach to patients with extrahepatic diseases are discussed.
Similar content being viewed by others
References and Recommended Reading
Zignego AL, Brechot C: Extrahepatic manifestations of HCV infetion: facts and controversies. J Hepatol 1999, 31:369–376.
Cacoub P, Renou C, Rosenthal E: Extrahepatic manifestations associated with hepatitis C virus infection: a prospective multicenter study of 321 patients. Medicine 2000, 79:47–56. Reports on a survey of symptom and laboratory evidence of extrahepatic manifestations in a large cohort of HCV patients. It is most notable because of the comprehensive look at multiple disorders in one survey.
DeCastro M, Sanchez J, Herrera JF, et al.: Hepatitis C virus antibodies and liver disease in patients with porphyria cutanea tarda. Hepatology 1993, 17:551–557.
El-Serag HB, Hampel H, Yeh C, Rabeneck L: Extrahepatic manifestations of hepatitis C among United States male veterans. Hepatology 2002, 36:1439–1445. These authors performed the largest case-control study in this field, using the clinical database of the VA Medical Centers to examine patterns of diagnostic coding as evidence of association between HCV and other disorders. Although the method is indirect, there are notable positive and negative data generated in this unique study.
Cacoub P, Ratziu V, Myers RP, et al.: Impact of treatment on extra hepatic manifestations in patients with chronic hepatitis C. J Hepatol 2002, 36:812–818.
Cacoub P, Poynard T, Ghillani P: Extrahepatic manifestations of chronic hepatitis C. Arthritis Rheum 1999, 42:2204–2212.
Herrero C, Vicente A, Bruguera M, et al.: Is hepatitis C virus infection a trigger of porphyria cutanea tarda? Lancet 1993, 341:788–789.
Mignogna MD, Muzio LL, Favia G: Oral lichen planus and HCV infection: a clinical evaluation of 263 cases. Int J Dermatol 1998, 37:575–578.
Cribier B, Garnier C, Laustriat D, Heid E: Lichen planus and hepatitis C virus infection: an epidemiologic study. J Am Acad Dermatol 1994, 31:1070–1072.
Pawlotsky JM, Ben Hayia M, Andre C, et al.: Immunological disorders in C virus chronic active hepatitis: a prospective case-control study. Hepatology 1994, 19:841–848.
Carson CW, Conn DL, Czaja AJ, et al.: Frequency and significance of antibodies to hepatitis C virus in polyarteritis nodosa. J Rheumatol 1993, 20:304–309.
Cacoub P, Lunel-Fabiani F, Du LT, et al.: Polyarteritis nodosa and hepatitis C virus infection. Ann Intern Med 1992, 116:605–606.
Marazuela M, Garcia-Buery L, Gonzalez-Fernandez B, et al.: Thyroid autoimmune disorders in patients with chronic hepatitis C before and during interferon-alpha therapy. Clin Endocrinol 1996, 44:635–642.
Mason AL, Lau JY, Hoang N: Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999, 29:328–333.
Misiani R, Bellavita P, Fenili D, Borelli G: Hepatitis c virus infection in patients with essential mixed cryoglobulinemia. Ann Intern Med 1992, 117:573–577.
Yamabe H, Johnson R, Gretch DR, et al.: Hepatitis C virus infection and membranoproliferative glomerulonephritis in Japan. J Am Soc Nephrol 1995, 6:220–223.
Ferri C, Francesco C, Zignego AL: Hepatitis C virus infection in patients with non-Hodgkin’s lymphoma. Br J Haematol 1994, 88:392–394.
Ferri C, Baicchi U, la Civita L, et al.: Hepatitis C virus-related autoimmunity in patients with porphyria cutanea tarda. Eur J Clin Invest 1993, 23:851–855.
Clifford BD, Donahue D, Smith L, et al.: High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology 1995, 21:613–619.
Custro N, Montalto G, Scafidi V, et al.: Prospective study on thyroid autoimmunity and dysfunction related to chronic hepatitis C and interferon therapy. J Endocrinol Invest 1997, 20:374–380.
Deutsch M, Dourakis S, Manesis EK, Gioustozi A: Thyroid abnormalities in chronic viral hepatitis and their relationship to interferon alfa therapy. Hepatology 1997, 26:206–210.
Boadas J, Rodriguez-Espinosa J, Enrequez J, et al.: Prevalence of thyroid autoantibodies is not increased in blood donors with hepatitis C virus infection. J Hepatol 1995, 22:611–615.
Prieto J, Yuste JR, Beloqui O, et al.: Anticardiolipin antibodies in chronic hepatitis C: implication of hepatitis C virus as the cause of the antiphospholipid syndrome. Hepatology 1996, 23:199–204.
Pawlotsky JM, Roudot-Thoraval F, Simmonds P: Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes. Ann Intern Med 1995, 122:169–173.
Johnson RJ, Gretch DR, Hideaki Y, et al.: Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 1993, 328:465–470.
Jefferson JA, Johnson RJ: Treatment of hepatitis C-associated glomerular disease. Semin Nephrol 2000, 20:286–292.
Perez-Calvo J, Lasierra P, Moros M, Inigo P: Role of ribavirin in membranoproliferative glomerulonephritis associated with hepatitis C virus infection refractory to alpha-interferon. Nephron 2002, 92:459–462.
Lacour JP, Bodokh I, Castanet J, et al.: Porphyria cutanea tarda and antibodies to hepatitis C virus. Br J Dermatol 1993, 128:121–123.
Fargion S, Piperno A, Cappellini MD, et al.: Hepatitis C virus and porphyria cutanea tarda; evidence of a strong association. Hepatology 1992, 16:1322–1326.
Chuang TY, Stitle L, Brashaer R, Lewis C: Hepatitis C virus and lichen planus: a case-control study of 340 patients. J Am Acad Dermatol 1999, 41:787–789.
Kerr GS, Rofail M, Lewis JH, et al.: Prevalence of hepatitis C virus associated cryoglobulinemia at a Veterans Hospital. J Rheumatol 1996, 24:2134–2138.
Lunel F, Musset L, Cacoub P, et al.: Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage. Gastroenterology 1994, 106:1291–1300.
Ferri C, Greco F, Longombardo G, et al.: Hepatitis C virus antibodies in mixed cryoglobulinemia. Clin Exp Rheumatol 1991, 9:95–96.
Misiani R, Bellavita P, Fenili D: Interferon alpha-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 1994, 330:751–756.
Naarendorp M, Kallemuchikkal U, Nuovo G: Long-term efficacy of interferon-alpha for extrahepatic disease associated with hepatitis c virus infection. J Rheumatol 2001, 28:2466–2473.
Silvestri F, Sperotto A, Fanin R: Hepatitis C and lymphoma. Curr Hepatitis Rep 2002, 1:5–8.
Ferri C, Monti M, Civita L, et al.: Hepatitis C virus infection in non-hodgkin’s b-cell lymphoma complicating mixed cryoglobulinaemia. Eur J Clin Invest 1994, 24:781–784.
Mazzaro C, Zagonel V, Monfardini S, Tulissi P: Hepatitis C virus and non-hodgkin’s lymphomas. Br J Haematol 1996, 94:544–550.
Silvestri F, Pipan C, Barillari G, et al.: Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders. Blood 1996, 87:4296–4301.
Silvestri F, Baccarani M: Hepatitis C virus-related lymphoma. Br J Haematol 1997, 99:475–480.
Collier J, Zanke B, Moore M, et al.: No association between hepatitis C and B-cell lymphoma. Hepatology 1999, 29:1259–1261.
Zuckerman E, Zuckerman T, Levine AM, et al.: Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma. Ann Intern Med 1997, 127:423–428.
Pioltelli P, Gargantini L, Cassi E, et al.: Hepatitis C virus in non-hodgkin’s lymphoma. A reappraisal after a prospective case-control study of 300 patients. Am J Hematol 2000, 64:95–100.
Lerat H, Rumm S, Hubersetzer F, et al.: In vivo tropism of hepatitis C virus genomic sequences in hematopoietic cells: influence of viral load, viral genotype and cell phenotype. Blood 1998, 91:3841–3849.
Andreone P, Zignego AL, Cursaro C, et al.: Prevalence of monoclonal gammopathies in patients with hepatitis C virus infection. Ann Intern Med 1998, 129:294–298.
Patriarca F, Silvestri F, Fanin R, et al.: Long-lasting complete remission of hepatitis C virus (HCV) infection and HCVassociated immunocytoma with alpha-interferon treatment. Br J Haematol 2001, 112:370–372.
Sperotto A, Silvestri F, Fanin R, et al.: Autologous stem cell transplantation in chronic carriers of hepatitis B virus and hepatitis C virus affected by onco-haematological diseases. Haematologica 1999, 84:1052–1053.
Huang MJ, Tsai SL, Huang BY, et al.: Prevalence and significance of thyroid autoantibodies in patients with chronic hepatitis C virus infection: a prospective controlled study. Clin Endocrinol 1999, 50:503–509.
Ganne-Carrie N, Medini A, Coderc E, et al.: Latent autoimmune thyroiditis in untreated patients with HCV chronic hepatitis: a case-control study. J Autoimmunity 2000, 14:189–193.
Fernandez-Soto L, Gonzalez A, Escobar-Jimenez F, Vazquez R: Increased risk of autoimmune thyroid disease in hepatitis C vs hepatitis B before, during, and after discontinuing interferon therapy. Arch Intern Med 1998, 158:1445–1448.
Ozyilkan E, Arslan M: Increased prevalence of diabetes mellitus in patients with chronic hepatitis C virus infection [letter]. Am J Gastroenterol 1996, 91:1480–1481.
Caronia S, Taylor K, Pagliaro L: Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999, 30:1059–1063.
Gray H, Wreghitt T, Stratton IM, et al.: High prevalence of hepatitis C infection in Afro-Caribbean patients with type 2 diabetes and abnormal liver function tests. Diabet Med 1995, 12:244–249.
Simo R, Hernandez C, Genesca J: High prevalence of hepatitis C virus infection in diabetic patients. Diabetes Care 1996, 19:998–1000.
Mehta SH, Brancati FL, Sulkowski MS, Strathdee S: Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med 2000, 133:592–599. These authors looked at the association between diabetes mellitus and HCV by using the NHANES III survey data. Thus far, this is the only study to use systematic screening in a sample and avoid selection bias.
Mangia A, Schiavone G, Lezzi G: HCV and diabetes mellitus: evidence for a negative association. Am J Gastroenterol 1998, 93:2363–2367.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fox, R.K. Hepatitis C virus outside the liver. Curr hepatitis rep 2, 116–124 (2003). https://doi.org/10.1007/s11901-003-0005-2
Issue Date:
DOI: https://doi.org/10.1007/s11901-003-0005-2